TP53 and ovarian carcinoma: By over-expressing specific TP53 mutations in TP53−/− ovarian cancer cell lines in vitro or by measuring tumorigenesis in mouse and rat models, studies have demonstrated a subset of mutations that increase chemo-resistance and promote cancer cell growth [37].